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Abstract
The investigation of immune senescence has uncovered many changes in B cell development,
maintenance, and function with increasing age. However, most of these studies have focused on
conventional B cell subsets in the spleen. The B-1 cell subset is an essential arm of the innate
immune system, which in general has been understudied in terms of immune senescence. Here, we
review what is currently known about B cells during aging and go on to describe why B-1 cell
biology is an important component of the aging immune system in the context of diseases that
most affect the aged population.
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The global life expectancy is rapidly increasing. In the year 2000, there were 605 million
people aged 60 years and over, and by the year 2050 the World Health Organization (WHO)
predicts that this age group will reach 2 billion. Numerous diseases are associated with
increased age, including heart disease, cancer, stroke, Alzheimer’s disease, diabetes,
influenza, and pneumococcal infection.1 The immune system plays a central role in many of
these diseases. In order to decrease the burden of disease as our population ages, it is
necessary to understand changes within the immune system with increasing age. In
particular, B cells play both adaptive and innate roles in diseases of the aged, which is the
focus of this article. Herein we will first review what is known about conventional B-2 cells
in the aged immune system, and then discuss the importance of widening our understanding
of the role B-1 cells play in two primary diseases of the elderly, Streptococcus pneumoniae
infection and atherosclerosis.
S. pneumoniae is the most common cause of pneumonia.2 In the United States alone, 40,000
people die each year from pneumococcal infection.2 The incidence of pneumococcal
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infection and the mortality rate increase dramatically in people over the age of 65, moving
from an average mortality rate of 0.92 in ages 5–49 to 6.7 in people over the age of 65.3
These numbers clearly reveal an alarming disparity between the two age groups, despite the
availability of a vaccine, PPSV23, approved for adults 65 years of age and older since
1983.2 Postvaccination antibody titers are the same in young adults (under the age of 45)
and elderly adults (over the age of 65); however, the elderly population contains antibodies
less effective at clearing bacteria.4 These data clearly demonstrate that pneumococcal
infections still pose a great challenge in prevention and treatment, particularly in the elderly
population, which immunization and B-2 cell adaptive immunity have not been able to
overcome.

Author Manuscript

Atherosclerosis is the number one cause of death globally, and its incidence increases
greatly in persons aged 65 and over.5 Blockage of arterial walls and subsequent rupture of
plaques causes heart attacks and strokes. Inflammation of the arterial wall endothelium leads
to arterial wall thickening and consequently plaque formation.6 The main cause of this
inflammation is increased levels of modified serum low-density lipoproteins (LDL), which
become trapped in the arterial wall.6 LDL is more antigenic after it becomes oxidized
(OxLDL), and this occurs once in the arterial wall.6 Remarkably, many studies have shown
that anti-OxLDL antibodies, B-1 cells, and B-1 cell–derived natural IgM are protective
against atherosclerosis.7,8 However, it is not completely understood how these antibodies
and/or B-1 cells are maintained throughout adult life. In order to maintain protection against
atherosclerosis, it is essential to understand how to maintain these protective antibodies with
increasing age.

Author Manuscript
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When optimizing vaccination strategies, enhancing passive protection, and/or developing
other treatments for mitigating pneumococcal infection and/or providing protection against
atherosclerosis, considering the roles of B lymphocytes is of great importance. B cells
produce antibodies that fight infection by (1) binding pathogens, thereby preventing them
from infecting host cells; (2) neutralizing toxins; (3) opsonizing pathogens; or (4) activating
complement, which coats pathogens and leads to opsonization and/or lysis. B cells also
function as antigen-presenting cells.9 Various subsets of B cells have been defined in both
mice and humans by their distinct phenotypic and functional characteristics. This brief
review will focus on murine B cells during aging, as aging of human B cells has been
reviewed elsewhere.10 In the mouse, these subsets include B-2 cells, which comprise
follicular (FO) and marginal zone (MZ) B cells found mainly in the spleen, and B-1 cells,
which include B-1a (CD5+) and B-1b (CD5−) cells found in the spleen, peritoneal cavity,
bone marrow (BM), and pleural cavity. Together, these B cell subsets provide immediate
(B-1 cells) and long-lasting (B-2 cells) protection against infection, whereas natural IgM and
B-1 cells provide protection from atherosclerosis.
Numerous studies have elucidated the age-related changes affecting conventional B-2 cells.
These changes occur from the earliest developmental stages throughout maturity. Going
forward, this extensive knowledge about B-2 senescence will be extremely valuable in
advancing the knowledge about B-1 cell senescence, which is currently limited.
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B cells in the aging immune system: development, maintenance, and
function
B cell development in the aging immune system
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B cell development begins with hematopoietic stem cells (HSCs). HSCs are self-renewing
pluripotent cells found in fetal liver and adult BM, which have the ability to give rise to all
blood cells.11 B cell development continues through a series of differentiation steps dictated
by expression of transcription factors, cytokines, and cell surface receptors. Proper
immunoglobulin rearrangement allows the B cell to progress through critical stages of
differentiation, culminating in a naive B cell expressing a B cell receptor (BCR), which is
necessary for B cell survival and response to antigen12 (Fig. 1). Each stage of B cell
development is marked by specific gene and surface marker expression [13, 14]. During
immunoglobulin rearrangement, non-templated (N) nucleotides can be added to the joins of
gene segments, which increases diversity of the receptor.15 B-2 cell development continues
throughout life in the BM of adult mice from specific B220+CD19− B cell progenitors.16
Conversely, the B-1 cell population originates mainly during fetal life and was thought to
persist throughout adult life only by self-renewal.17. Only recently, Dorshkind and
colleagues identified a B-1 cell–specific progenitor, Lin−CD45lo/−CD19+, found in low
numbers in the adult BM and abundantly in the fetal liver.18 Due to the recent understanding
that B-1 cell progenitors are present in adult BM, little is known about how aging affects
B-1a cell development and/or maintenance. However, B-2 cell development in the aged
immune system has been shown to be impaired as a result of both intrinsic and extrinsic
factors.

Author Manuscript
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First, we will discuss the effects of aging upon HSCs, which is where B cell development
begins. The number of HSCs has been shown to increase with age, do functional defects
including self-renewal and homing defects.19 Despite the increase in number, transfer
experiments demonstrate that HSCs from aged mice are less effective at generating both B
and T cells as compared to young mice, (reviewed in Ref. 20). Interestingly, transferring
aged whole bone marrow (WBM) into young recipients generates the same frequency of B
cells as transferring WBM from young donors.21 However, when HSCs were purified from
BM of aged donors and then transplanted into young recipients, B cells are not readily
detected.22,23 These seemingly contradictory results have been hypothesized to be due to
age-related changes in the surface phenotype of HSCs23 and cell-intrinsic defects related to
homing.21 Different phenotypic subsets of HSCs have been described (reviewed in Ref. 19).
It is possible that the different subsets’ surface phenotypes change with age, which could
alter reconstitution results upon purification of certain HSC subsets owing to loss or
exclusion. WBM, on the other hand, would contain all subsets of HSCs regardless of
changes in surface phenotype. Interestingly, these studies also revealed an increase in
myeloid differentiation from aged WBM21 and purified HSCs.22 It was subsequently shown
that HSC potential for myeloid or lymphoid differentiation can be divided by CD86
expression (CD86−CD150+ and CD86+CD150+, respectively), and the HSCs with myeloid
potential were increased in aged BM whereas the HSCs with lymphoid potential were
reduced.24 Together, these studies demonstrate changes in aged HSCs, which could lead to
further alterations seen in B cell development in the BM.
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The next steps in development from HSCs to a committed B cell progenitor are also
associated with changes during aging. HSCs first develop into non–self-renewing
multipotent progenitors (MMP), followed by lymphoid-primed multipotent progenitors
(LMPP), early lymphoid progenitors (ELP), common lymphoid progenitors (CLP) (which
are also called early B cell precursors (EBP)), and then progress to pre-pro B cells23,25 (Fig.
1). Commitment to the B cell lineage is dependent upon expression of a number of
transcription factors, including Ikaros, Pu.1, E2A (E12/E47), EBF (early B cell factor), and
PAX-5.23 In particular, E2A and EBF act together to direct CLPs toward B cell
commitment, and, as will be described herein, also have other significant roles throughout B
cell development.26 E2A plays a role in the commitment of both MPPs and LMPPs to
lymphoid versus myeloid lineages;26 however, the effect of aging upon E2A expression and
function in MMPs or LMPPs has not yet been studied despite the age-related decrease in
these populations.27 A decrease in the number of CLPs has also been observed in aged
mice,27,28 as well as a decrease in the number of pro-B28 and pre-B cells29 found in the BM
of aged mice. It was proposed that the decrease in early B cell precursors results from
defects in transcription regulated by E2A/EBF proteins,27,30,31 which aid in early B cell
specification and differentiation from MMPs, LMPPs, and CLPs to pro-B cells.26 This
hypothesis is supported by the findings that both stem cells and CLPs from aged mice have
reduced potential to produce B cells, and Ebf1 is reduced in CLPs from aged mice, which, if
restored, can reestablish B cell generation from aged CLPs.27 These results demonstrate that
cell-intrinsic defects affect aged CLPs and early stages of B cell differentiation. However, it
has also been shown that cell-extrinsic defects or BM microenvironment defects also play
roles in age-related changes leading to a decrease in pro- and pre-B cell numbers in the aged.

Author Manuscript
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Interestingly, both cell intrinsic and extrinsic defects affect the early stages of B cell
development. IL-7 receptor α chain (IL-7Rα) expression is first seen in the CLP stage. IL-7
is secreted by BM stromal cells and is necessary for the survival and continued development
of FO B-2 cell progenitors. However, IL-7 is not necessary for MZ B cells or B-1 cell
progenitors, whereas the IL-7Rα chain is necessary for all B cell subset progenitors.32 Early
in the CLP stage, IL-7 signaling is necessary for the induction of the transcription factor
EBF1, which is required for initiation of immunoglobulin gene rearrangement and therefore
differentiation into the pre-pro-B cell stage of development.26,33 It has been shown that aged
pro-B cells have an impaired ability to respond to IL-7 despite the normal expression level
of IL-7R.34 Interestingly, transfer of aged BM into young recipients yielded numbers of preB cells seen in young mice; however, transfer of young BM into aged recipients yielded a
decrease in the numbers of pre-B cells, which are normally observed in aged mice.35 These
results point to a defect in the BM microenvironment. Along these lines, it has been
demonstrated that BM stromal cells from aged mice are defective in releasing IL-7.34
Furthermore, BM stromal cells from aged mice increase the production of the chemokine
RANTES, which promotes myeloid differentiation and inhibits lymphoid differentiation.36
These studies clearly demonstrate that extrinsic factors play a role in age-related changes in
B lymphopoiesis.
The roles that cell-intrinsic defects play in the loss of pro-B and pre-B cells in the aged have
been studied extensively. The pro-B cell stage of development is initiated by the assembly of
the BCR, which begins with homologous recombination of germline heavy chain genes to
Ann N Y Acad Sci. Author manuscript; available in PMC 2016 December 01.
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form the variable region and continues through the pre-BII stage where homologous
recombination of the light chain genes occur (reviewed in Ref. 37). The variable region of
the heavy chain comprises three gene segments: variable (V), diversity (D), and joining (J),
whereas the light chain comprises two: (V) and (J). Rearrangements of these segments are
regulated by recombination signal sequences (RSS), which flank the segments. In addition,
the RSS serves as the binding site for the proteins RAG-1 and RAG-2, which once bound to
each RSS cleave the DNA between the coding sequence and RSS. After cleavage by RAG-1
and RAG-2, the coding ends remain as hairpin loops that are opened by the Artemis–DNAPK complex. The opening of the coding ends by Artemis–DNA-PK sometimes results in
palindromic DNA sequences, referred to as P-nucleotides. Next, non-templated nucleotides
(N-nucleotides) are added to the single stranded ends of the hairpins by the enzyme terminal
deoxynucleotidyl transferase (TdT). Finally, DNA repair enzymes remove unpaired
nucleotides and the two single stranded coding ends are ligated. It has been shown that both
Rag2 and recombinase activity are decreased in pro-B cells of aged mice,35 which would
decrease the pre-B cell pool. E2A expression is also decreased in pro-B cells from aged
mice,27,30,31 which contributes to decreased expression of Pax-5 and increased turnover of
Pax-5.38 Pax-5 expression is required for B cell progenitors to remain committed to the B
cell lineage throughout development through repression of non-B lineage genes in pro-B
cells.39 These results demonstrate that, in addition to the cell-extrinsic defects described
above, cell-intrinsic defects present in aged pro-B cells also lead to decreased numbers of
pro-B cells in aged mice. Similar results have been shown for pre-B cells.
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Once pro-B cells finish assembly of the heavy chain, they enter the pre-B cell stage. At this
stage, the rearranged heavy chain pairs with VpreB and lambda 5, which together make up
the surrogate light chain and is regulated by E2A and EBF1.40 Rearrangement of the light
chain (V) and (J) regions occurs in the pre-BII stage. In light of the fact that E2A is
decreased in aged pro-B cells and regulates transcription of the surrogate light chain genes,
it is not surprising that aged pro-B/early pre-B cells show reduced surrogate light chain
expression, which consequently leads to reduced pre-BCR expression.31 It has been
suggested that low surrogate light chain expression can lead to a more autoreactive
repertoire, due to a less stringent pre-BCR checkpoint.41 In fact, serum autoantibodies have
been shown to increase with age.42 E2A and EBF1 also promote transcription of RAG
genes, which are required during both pro-B and pre-B cell development.26 Overall, these
studies demonstrate that E2A, EBF1, and Pax-5 play central roles in the reduced number of
pro and pre-B cells in aged mice.
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It is not known to what extent the aged BM environment contributes to these observed
defects; however, IL-7 signaling is necessary for Ebf1 induction, yet BM stromal cells are
defective in releasing IL-7. Furthermore, mature B cells in the periphery of aged mice have
been shown to affect B lymphopoiesis. Increased longevity of peripheral mature B cells in
aged mice43 has recently been shown to play a role in the reduced numbers of B cell
progenitors. This study eloquently demonstrated that depletion of mature B cells lead to an
increase in pro-B cells, pre-B cells, MMPs, and CLPs.44 It has been further hypothesized
that, owing to the increased longevity of mature peripheral B cells, there is a decrease in the
need for B cell generation, which HSCs sense and which leads to their increased myeloid
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potential.45 Together, these studies indicate that aging has far-reaching effects upon B cell
development; from the earliest stem cells, to committed lymphoid progenitors, to committed
B cell progenitors, and even to the longevity of mature B cells, which in turn has
consequences for early B cell development (Fig. 2). However, further investigation is
required to elucidate how the interplay between cell-extrinsic and cell-intrinsic changes
influence the aged immune system.
Mature B cells in the aging immune system

Author Manuscript
Author Manuscript

In addition to developmental impairment, mature peripheral B cells display altered
maintenance and function in the aged immune system. Aged mice display a decrease in B
cell diversity46,47 and an increase in long-lived B cells,43 which, in a transgenic model
favoring selection, have been shown to be the result of an increase in antigen-experienced B
cells.48 Despite the decrease in pro-B, pre-B, and immature B cell subsets, the number of FO
B cells is only slightly decreased in aged animals.49 In the case of MZ B cells, a significant
decrease has been demonstrated in aged mice as compared to the young.50 Furthermore, the
aged splenic environment causes a decrease in migration of immature and MZ B cells.51
However, with advancing age, there is an increase in a subset of B cells termed ageassociated B cells (ABCs), which are found in both the spleen and BM.52 These B cells are
shown to arise from exhaustively expanded mature B cells. Interestingly, ABCs produce
TNF-α, which has been shown to induce apoptosis in pro-B cells.53 It is still not clear if the
cell-intrinsic and cell-extrinsic changes occurring during early B development are the
initiating factors leading to the increase in peripheral B cell longevity, which then
propagates the decrease in B cell development, or if the long-lived peripheral B cells
initiated the decrease in B lymphopoiesis. Regardless, the changes in B cell development
(described above) and peripheral B cell characteristics may lead to the decreased repertoire
diversity observed in aged B cells.
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Responses to antigens and the ability to produce effective antibodies are defective in the
aged immune system. B cells produce high-affinity antibodies within the germinal center
(GC), where antibodies undergo affinity maturation and somatic hypermutation. However,
there is a decrease in the number and volume of GCs formed in aged mice.54 In addition,
aged mice display reduced somatic hypermutation (SHM), reduced class-switch
recombination (CSR), and decreased AID expression, which is required for both SHM and
CSR.30 Interestingly, E2A expression is also decreased in aged mature splenic B cells and is
required for AID expression.30 Therefore, mature B cells from aged mice have defects in the
mechanisms used to generate effective antibodies. These defects may have consequences
upon generation of antibodies for diseases affecting the elderly such as S. pneumoniae
infection.
After immunization of old mice, the amount of antibody produced is not always changed,
but the affinity to the specific antigen is severely decreased.55 This has been shown to be the
case for the pneumoccal vaccine in the elderly.56 The B cell repertoire pre- and
postimmunization is also different in aged mice. In the case of antibodies to
phosphorylcholine (PC), a cell wall epitope of S. pneumoniae, older mice show usage of a
variety of VH genes other than the restricted VH1 utilized by the T15 idiotype of younger
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mice.46 Significantly, these anti-PC antibodies found in older mice have been shown to be
less protective than the T15 idiotype found in young mice.57,58 Together, these studies
suggest that immunization in the aged does not elicit the generation of protective antibodies.
Consequently, the aged individual is dependent upon natural IgM and/or previously formed
memory for protection against S. pneumoniae infection. At the time of these reports, much
of B-1 cell biology was unknown. Therefore, many of these differences observed in aged
mice are still not fully understood. Today, we are able to precisely collect and study various
subsets of B-1 cells, and it has been clearly demonstrated that B-1a cells are required to clear
S. pneumonia.59 Thus, although we now know B-1a cells are essential for the maintenance
of health, the role B-1a cells play in the aging immune system has yet to be fully
investigated.

B-1 cells: essential protective role in diseases of the elderly
Author Manuscript

Role of B-1–derived natural IgM

Author Manuscript

B-1a cells are phenotypically characterized by cell surface markers: CD5+ IgMhigh IgDlow
B220low MAC-1+ CD23− CD43+.60 B-1 cells residing in the BM and spleen produce 80% of
the natural, non-immune serum IgM in mice.17 Natural IgM is non-immune, polyreactive,
low-affinity immunoglobulin (Ig) that functions in infection, atherosclerosis, B cell
homeostasis, inflammation, and autoimmunity (reviewed in Ref. 61). It is able to bind
conserved structures, sometimes more than one, on organisms, and thereby neutralize and
facilitate the removal of such infectious agents. The unique ability of natural antibodies to
play this essential role in the immune system is afforded by their structure, both in the
constant and variable regions. IgM is mainly in the pentameric form, which effectively binds
the complement component C1q and is important for both the clearance of pathogens and
removal of apoptotic cells.61 Natural IgM produced by B-1 cells is also germ line like, as
evidenced by the relative lack of N-region additions, and has a more restricted repertoire.62
B-1 cell–derived natural IgM is essential for (1) controlling bacterial and viral infections,17
(2) aiding in the elimination of excess autoantigens that are increased in the elderly through
removal of apoptotic cells,61 and (3) binding oxidized low-density lipoprotein (OxLDL), in
particular by antibodies bearing the T15 idiotype, which helps control the inflammatory
process leading to atherosclerotic plaques.7 Given these functions, B-1 cell–derived natural
antibody has been shown to play essential protective roles in two diseases that significantly
affect the elderly, S. pneumoniae infection and atherosclerosis.

Author Manuscript

Due to the germ line–like Ig and restricted repertoire, B-1 cell–derived natural IgM is
evolutionarily conserved, which affords its ability to control bacterial infections. IgM
produced by B-1 cells recognizes phosphatidylcholine (PtC) and other discrete microbial
cell wall determinates such as PC from S. pneumoniae. In particular, anti-PC antibody
derived from B-1a cells has been well characterized and shown to be protective against S.
pneumoniae infection.59,63 The importance of anti-PC and anti-pneumococcal capsular
polysaccharide 3 (PPS3) germ line–like natural antibodies was shown in mice lacking B-1a
cells, as they were unable to survive acute infection with S. pneumonia.59 N-addition has
been shown to play a key role in antigen receptor diversity and antibody effectiveness to
certain pathogens. The prototypical B-1a anti-PC antibody, T15, has no N-addition.63,64
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Remarkably, TdT transgenic mice vaccinated with heat-killed S. pneumoniae generated an
anti-PC response, but these anti-PC antibodies were not protective against S. pneumoniae
infection.65 This study demonstrates that the increased diversity generated by N-addition can
be detrimental for microbial protection, and highlights the importance of structure in the
protection provided by evolutionarily conserved natural antibody.
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Anti-PC natural antibody, in particular T15, has also been shown to be protective in
atherosclerosis. Natural antibodies to OxLDL have been observed in healthy individuals
over the age of 10066 and in healthy mice, and were subsequently shown to be identical to
the anti-PC T15 clone.67 Interestingly, when atherosclerosis-prone mice were injected with
heat-killed S. pneumonia, they exhibited high levels of serum anti-OxLDL IgM and reduced
atherosclerosis.68 More recently, it has been demonstrated that mice deficient in secretory
IgM or C1q develop increased atherosclerotic lesions as compared to mice with serum IgM
or C1q.61,69 It has also been shown that treatment of mice that have advanced
atherosclerosis with natural IgM reduces disease and increases anti-OxLDL levels.70 In
accordance with these studies, it has been demonstrated that B-1a cells and B-1a cell–
derived natural IgM are protective against atherosclerosis.8 Together, these studies establish
a protective role for natural antibodies and B-1a cells in atherosclerosis.
B-1 cells’ unique ability to produce protective natural IgM: a role for development

Author Manuscript
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As mentioned above, the B-1 cell population originates during fetal life and persists
throughout adult life through self-renewal.71–73 More recently, it was demonstrated that the
B-1 cell–specific progenitor (B1P), AA4.1+Lin−CD45Rlow/−CD19+, is found in both the
fetal liver (FL) and adult BM.18 Other groups have also independently shown that total
lineage-negative BM can give rise to B-1a cells.74–76 During fetal development, the enzyme
mediating increased junctional diversity by way of N-region additions, TdT, is not
expressed.77 This lack of TdT expression during fetal life allows natural germ line–like
antibodies to develop lacking N-additions. Presumably, different selection pressures during
fetal life also contribute to the development of these protective natural antibodies. We have
recently demonstrated that transfer of fetal liver B1P into adult SCID mice produces B-1a
cell IgM with few N-additions; however, transfer of the BM B1P into adult SCID mice
produces B-1a cell IgM with abundant N-additions.78 In accordance with these results,
assessment of TdT gene expression revealed high levels of TdT in the B1P from the adult
BM and no expression in the B1P from FL. However, upon transfer of
AA4.1−Lin−CD45R−CD19− fetal liver cells into adult SCID mice, we found that B-1a cells
originating from this population produced IgM with abundant N-additions, despite the lack
of TdT expression. The mechanism for this is still unclear, but suggests that
AA4.1−Lin−CD45R−CD19− fetal liver cells may contain cells that, once in the BM,
differentiate into AA4.1+Lin−CD45Rlow/−CD19+ cells (B1P) and acquire TdT. This
hypothesis would fit well with previous reports demonstrating that HSCs and CLPs from
adult BM are inefficient at generating B-1a cells.79,80 Interestingly, fetal liver and neonatal
HSCs efficiently generate B-1a cells. The reason for this discrepancy is still not understood,
but it is hypothesized that changes in the hematopoietic environment play a role (reviewed
in Ref. 81). Together, these results demonstrate that the unique developmental environment
in which B-1 cells derive plays a role in the generation of protective natural IgM. However,
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much of how this development is maintained throughout adulthood and into old age is
unknown.

B-1 cells in the aging immune system

Author Manuscript

Despite the number of years B-1 cells have been studied, there is a large gap in our
knowledge about B-1 cell biology in the aged. The most well-known feature of B-1 cells in
the aging immune system is their general expansion.82 There is an increase in the number of
anti-PC B cells in adult mice with age; however, these anti-PC antibodies were shown to
originate from newly generated BM B cells and do not have the canonical T15 idiotype.46
This difference in VH usage would be predicted since these newly generated anti-PC B cells
are not being generated during fetal life. Furthermore, studies have demonstrated that nonT15 anti-PC antibodies are less protective.46,65 Changes in repertoire with age have also
been demonstrated for the quintessential B-1 cell specificity, PtC, which utilizes VH11,
VH12, and Q52 (VH2). It has been shown that aged splenic B cells utilize the variable
heavy chains VH11 and Q52 more often than splenic B cells from young mice.47 However,
another study demonstrated a selective increase in VH12 and not VH11 usage in peritoneal
B-1 cells with increasing age.83 Interestingly, B-1 cells obtained from aged mice have also
been shown to produce antibody with abundant N-additions.74,84 Together, these findings
have stimulating implications for B-1 cell maintenance with age.

Author Manuscript

As described above, BM-derived (BMD) B-1a cells have abundant N-region additions and
do not express the same level of repertoire skewing as fetal liver–derived B-1a cells.74
Furthermore, native B-1a cells from aged mice contain more N-region additions than those
from young mice.74,84 It has also been shown that the number of BM B-1 cell progenitors
does not change with age.85 Together, these results suggest that adult BM progenitors could
contribute to the B-1a cell pool over time, thereby changing the spontaneously secreted
germ line–like IgM shown to be required for immediate protection against S. pneumoniae
infection and atherosclerosis. From these studies, we hypothesize that the level of natural
IgM protection changes with age as a result of functional and/or repertoire-associated
alterations to the B-1a cell pool over time. However, many studies are needed to fill in the
large gap in our knowledge of B-1 cell biology with increasing age.

Future focus: innate B cells in aging

Author Manuscript

Clearly, B-1 cell natural antibody plays an essential role in protection from S. pneumoniae
infection and atherosclerosis. Nevertheless, our understanding of how this essential arm of
the immune system changes with age is greatly lacking. Our knowledge about B-1 cells has
grown exponentially to define new subsets and functions and a specific progenitor, and it
even extends to defining a human equivalent (reviewed in Ref. 86). In addition, our
understanding of how natural IgM is secreted and which subsets secrete natural antibody has
been refined.87–89 However, we are clearly lacking in understanding how B-1a cell
development, different subsets, and functions are affected by the aging process. Careful
consideration should also be taken of the strain and sex of the mice analyzed. In our own
studies, we have found no expansion of B-1 cells in aged male mice, but preliminary results
suggest expansion in female mice (unpublished observations). Along these lines, diet and
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SPF status might also influence aging studies of mice. Building upon the model set forth by
Dorshkind and Montecino-Rodriguez, we suggest possible mechanisms leading to B-1 cell–
derived IgM with abundant N-additions with age based on the current literature (Fig. 3).
This is just a speculative model, and we anticipate that with more research, especially
research focused on maintenance and aging, the precise mechanisms will be worked out.
Understanding these mechanisms will most certainly provide the necessary insight to
improve the health of the aging population.

Conclusions

Author Manuscript

The B-1a cell population is capable of producing antibodies that provide immediate
protection against S. pneumoniae and confer protection against atherosclerosis in young
mice. While much is known about conventional B-2 cell subsets, the B-1 cell subset has not
been well studied in aged mice to date. Such studies directed at understanding the biology of
this unique B cell subset in aged mice will greatly improve our ability to design preventative
strategies and/or treatments of S. pneumoniae infection in the elderly. In addition, the natural
antibodies produced by B-1a cells help reduce the onset of atherosclerosis.90,91 Therefore,
the knowledge gained from further study will not only aid in understanding of this protective
B cell subset for preventative strategies and/or treatments of S. pneumoniae infection but
also will further our knowledge of therapeutic strategies for atherosclerosis.
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B cell development. B cell development begins with hematopoietic stem cells (HSCs) and
continues through a series of differentiation steps dictated by expression of transcription
factors, cytokines, and cell surface receptors. Long-term repopulating HSCs (LT-HSCs) and
short-term HSCs (ST-HSCs) are named for their capacity to self-renew. The HSCs first
differentiate into multipotential progenitors (MPP). Upon signaling through Flt-3, the MPPs
differentiate into lymphoid-primed multipotential progenitors (LMPP), which differentiate
into common lymphoid progenitors (CLP) upon Flt-3 and IL-7 signaling. Induction of the
transcription factors E2A and EBF mark the differentiation of the CLP into a pre-pro B cell,
commonly referred to as fraction A. E2A and EBF allow immunoglobulin rearrangement to
begin, which is necessary for the development of B cells. Proper immunoglobulin
rearrangement allows for the B cell to progress though each stage of differentiation, ending
in a naive B cell, which can migrate into the periphery. Each stage of B cell development is
marked by specific gene expression and surface marker expression as shown.
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Figure 2.

The aged developing and mature B cell pools. Both cell-intrinsic and cell-extrinsic changes
occur throughout the stages of B cell development ranging from pre-lymphoid commitment
(HSCs) to immature B cells. The mature B-2 cell pool in aged mice consists of follicular
(FO) B cells, marginal zone (MZ) B cells, and age-associated B cells (ABC). Black arrows
depict the relative increase or decrease in the differentiation subsets leading to mature B cell
development. The asterisk (*) above fraction B/C denotes additional changes in the cells in
the aged, which include decreased RAG and E2A expression.
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Figure 3.
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B-1 cell development and maintenance with age. Building upon the model proposed by
Motecino-Rodriguez and Dorshkind,81 we add what is currently known about the distinct
waves of B-1 cell development leading to an adult pool of B-1a cells and propose extending
the model to encompass changes with increasing age. (1) During the first wave of
development, B-1 cell progenitors (AA4.1+Lin−CD45Rlow/−CD19+) are derived from yolk
sac (YS) and para-aortic splanchnopleura (PSp) endothelium,92 before the emergence of
HSCs. Whether this first wave of B-1 cells contributes to the adult pool of B-1 cells is still
being examined. (2) The fetal liver and bone marrow is the site of the second wave of
development. Current data has shown that HSCs are capable of giving rise to B-1 cells
during fetal life, whereas HSCs present in the adult bone marrow are significantly less
efficient at producing B-1 cells.79 It is not yet known whether HSCs have specified
differentiation potential or if they lose their potential to produce B-1 cells in the adult. To
indicate these possibilities, we have chosen a different color for HSCs producing B-1 cells
during fetal life (green) versus those giving rise to B-2 cells (gray), which have limited
development during fetal life. It has been shown that there is commitment to either B-1 or
B-2 lineage at the CLP stage.81 Our recent results demonstrate that
AA4.1−Lin−CD45R−CD19− fetal liver cells (NEG, light green circles) give rise to B-1 cells
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with increased diversity (abundant N-additions) upon transfer into adult SCID mice,
whereas transfer of the fetal liver–derived B-1 cell progenitors
(AA4.1+Lin−CD45Rlow/−CD19+) into adult SCID mice yields B-1 cells with limited Nregion additions. These results suggest that an earlier population may differentiate into B-1
cell progenitors giving rise to more than one type of B-1 cell progenitor (red circle versus
light blue circles), although whether this happens physiologically is not known. Either way,
B-1 cells that develop during fetal and neonatal life have limited N-additions. (3) The third
wave of development occurs in the adult bone marrow and mainly yields B-2 cells. We
hypothesize that a possible mechanism of non-HSC–dependent B-1 cell development during
adult life might occur via the NEG population of fetal liver cells that have migrated to the
adult bone marrow. Furthermore, this adult development of B-1 cells would produce B-1
cells with increased N-additions, contributing to the change in B-1 cell –derived natural IgM
with age.
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